← Back to headlines
US Executive Action to Advance Ibogaine Research Welcomed by Psyence BioMed
Psyence BioMed has welcomed a recent U.S. executive action aimed at advancing research into Ibogaine, a psychedelic compound with potential therapeutic applications.
17 Apr, 13:15 — 17 Apr, 13:15
Sources
Showing 1 of 1 sources



